Login to Your Account

Expanding Redx Inks Cancer Alliance with Pharmascience

By Nuala Moran
Staff Writer

Wednesday, May 8, 2013
LONDON – Redx Pharma Ltd. has unveiled a shift in strategy away from a sole focus on internally generated compounds, with the in-licensing of an early stage oncology program from Canadian biotech Pharmascience Inc.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription